Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cellulophaga omnivescoria strain:MSK1

ABSTRACT: Cellulophaga omnivescoria strain:MSK1 Genome sequencing

PROVIDER: PRJNA917471 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR23086700_subreads.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

RNA-seq of Cellulophaga baltica phage 18:3 infection

Project description:Genome-wide transcriptomics (RNA-seq) data was obtained temporally at 0, 15, 30, 45, 60 and 120 minutes of the infection with phage 18:3 on Cellulophaga baltica strain #18 to analyze, in biological triplicates, the phage and host transcriptional response during their interaction compared to the uninfected control.

2017-03-20 | E-MTAB-5448 | biostudies-arrayexpress

Cellulophaga lytica strain:DAU203

Project description:Cellulophaga lytica strain:DAU203 Genome sequencing

| PRJNA317518 | ENA

Cellulophaga lytica strain:HI1

Project description:Cellulophaga lytica strain:HI1 Genome sequencing

| PRJNA256111 | ENA

Cellulophaga lytica strain:FXS1

Project description:Cellulophaga lytica strain:FXS1 Genome sequencing

| PRJNA678528 | ENA

Cellulophaga omnivescoria strain:W5C

Project description:Cellulophaga omnivescoria strain:W5C Genome sequencing and assembly

| PRJNA338344 | ENA

Cellulophaga baltica strain:14

Project description:Cellulophaga baltica strain:14 Genome sequencing and assembly

| PRJNA552277 | ENA

Cellulophaga baltica 18 strain:18

Project description:Cellulophaga baltica 18 strain:18 Genome sequencing

| PRJNA209292 | ENA

Cellulophaga baltica 4 strain:4

Project description:Cellulophaga baltica 4 strain:4 Genome sequencing

| PRJNA208989 | ENA

MSK1 regulates luminal cell differentiation and metastatic dormancy in breast cancer

Project description:For many breast cancer (BCa) patients, symptomatic bone metastases appear after years or even decades of latency. How metastatic cells disseminate, and how micrometastatic lesions remain dormant and undetectable yet initiate colonization, are major questions in cancer research. Here we identify and functionally analyse a molecular mechanism involved in bone metastatic latency of estrogen receptor–positive (ER)+ BCa. We developed an in vivo loss-of-function, genome-wide shRNA screening to identify genes relevant for long-latent relapse in BCa. This screen revealed the kinase MSK1 as an important regulator of metastatic dormancy. Importantly, low MSK1 expression associates with early metastasis in ER+ BCa patients. Reduced MSK1 levels impaired cellular differentiation and increased the bone homing and growth capacity of metastatic cells. MSK1 modulates chromatin status at promoters to regulate the expression of luminal differentiation genes, including those for the GATA-3 and FOXA1 transcription factors, which prevent the progression of ER+ BCa towards metastasis. Our results identify the regulation of luminal cell differentiation by MSK1 via modulation of chromatin remodelling to be a key mechanism for controlling metastatic dormancy in BCa. We propose that MSK1 could be a useful marker for stratifying BCa patients as high- or low-risk for early relapse, allowing patients to receive appropriate treatments.

2017-11-13 | GSE100306 | GEO

Cellulophaga baltica 13 strain:13

Project description:Cellulophaga baltica 13 strain:13 Genome sequencing and assembly

| PRJNA209291 | ENA